Activation of the RIG-I signaling pathway inhibits the related signaling molecules TRAF2 and NF-κB, thereby exerting the anti-inflammatory properties of PNS in cerebral ischemia. The gene discussed is TRAF2; the disease is Cerebral ischemia.